Records and reported status
Feb 10, 2025 FDA drug enforcement
Lack of Assurance of Sterility: There is a potential for leakage at the IV bottle port.
Class II Reported terminated
Distribution: US Nationwide.
Official source for Sodium Chloride Injection 9%, USP, 500 mL, Single-Dose IV Bottle, Rx Only, nephron, 503B outsourc... Feb 22, 2023 FDA drug enforcement
Lack of Assurance of Sterility
Class II Reported terminated
Distribution: Nationwide in the USA
Official source for Diltiazem HCl in 0.7% Sodium Chloride Injection, 125 mg/125 mL (1 mg/mL), 125 mL Single-Dose Cont... Feb 22, 2023 FDA drug enforcement
Lack of Assurance of Sterility
Class II Reported terminated
Distribution: Nationwide in the USA
Official source for Norepinephrine Bitartrate in 0.9% Sodium Chloride Injection, USP, 8 mg/250 mL (32 mcg/mL*), 250 m... Feb 22, 2023 FDA drug enforcement
Lack of Assurance of Sterility
Class II Reported terminated
Distribution: Nationwide in the USA
Official source for Norepinephrine Bitartrate in 0.9% Sodium Chloride Injection, USP, 4 mg/250 mL (16 mcg/mL*), 250 m... Feb 22, 2023 FDA drug enforcement
Lack of Assurance of Sterility
Class II Reported terminated
Distribution: Nationwide in the USA
Official source for Norepinephrine Bitartrate in 0.9% Sodium Chloride Injection, USP, 16 mg/250 mL (64 mcg/mL*), 250 ... Feb 22, 2023 FDA drug enforcement
Lack of Assurance of Sterility
Class II Reported terminated
Distribution: Nationwide in the USA
Official source for Phenylephrine HCl Injection, USP, 1 mg/10 mL (100 mcg/mL), 10 mL Single-Dose Vial, packaged in 30... Feb 22, 2023 FDA drug enforcement
Lack of Assurance of Sterility
Class II Reported terminated
Distribution: Nationwide in the USA
Official source for Phenylephrine HCl Injection, USP, 0.4 mg/10 mL (40 mcg/mL), 10 mL Single-Dose Vial, packaged in 3... Feb 22, 2023 FDA drug enforcement
Lack of Assurance of Sterility
Class II Reported terminated
Distribution: Nationwide in the USA
Official source for Phenylephrine HCl Injection, USP, 0.8 mg/10 mL (80 mcg/mL), 10 mL Single-Dose Vial, packaged in 3... Feb 22, 2023 FDA drug enforcement
Lack of Assurance of Sterility
Class II Reported terminated
Distribution: Nationwide in the USA
Official source for Phenylephrine HCl in 0.9% Sodium Chloride Injection, USP, 50 mg/250 mL (200 mcg/mL), 250 mL Singl... Jan 6, 2023 FDA drug enforcement
Lack of Assurance of Sterility
Class II Reported terminated
Distribution: Nationwide in the USA.
Official source for Rocuronium Bromide Injection, 50 mg/5 mL (10 mg/mL), 5 x 5 mL Pre-Filled Syringe, 6 x 5 syringe c... Nov 10, 2022 FDA drug enforcement
CGMP Deviations: Potential for cross contamination due to product carry over.
Class II Reported terminated
Distribution: Nationwide in the USA
Official source for PF-Labetalol HCl Injection, USP 20 mg/4 mL (5 mg/mL) vial, Rx Only, Nephron 503B Outsourcing Faci... Nov 10, 2022 FDA drug enforcement
CGMP Deviations: Potential for cross contamination due to product carry over.
Class II Reported terminated
Distribution: Nationwide in the USA
Official source for PF-Neostigmine Methylsulfate Injection, USP 3 mg/3 mL (1 mg/mL) vial, Rx Only, Nephron 503B Outso... Aug 10, 2022 FDA drug enforcement
CGMP Deviations: Potential for cross-contamination due to product carryover during manufacturing.
Class II Reported terminated
Distribution: Nationwide in the USA
Official source for PF-Neostigmine Methylsulfate Injection, USP, 3 mg/3 mL (1 mg/mL), One 3 mL Unit-Dose Vial, packag... Aug 10, 2022 FDA drug enforcement
CGMP Deviations: Potential for cross-contamination due to product carryover during manufacturing.
Class II Reported terminated
Distribution: Nationwide in the USA
Official source for Trisodium Citrate 0.5% Solution, (0.5%/4L), contains Per Liter: Sodium 140 mmol/L, Chloride 86 mm... Aug 10, 2022 FDA drug enforcement
CGMP Deviations: Potential for cross-contamination due to product carryover during manufacturing.
Class II Reported terminated
Distribution: Nationwide in the USA
Official source for PF-0.125% Bupivacaine HCl Injection, USP, 625 mg/500 mL (1.25 mg/mL), 500 mL bag, packaged in 10 ... Aug 10, 2022 FDA drug enforcement
CGMP Deviations: Potential for cross-contamination due to product carryover during manufacturing.
Class II Reported terminated
Distribution: Nationwide in the USA
Official source for PF-Labetalol HCl Injection, USP, 20 mg/4 mL (5 mg/mL), One 4 mL Unit-Dose Vial, packaged in 30 x ... Jun 30, 2022 FDA drug enforcement
Lack of Assurance of Sterility
Class II Reported terminated
Distribution: Nationwide in the USA
Official source for Amino Acid Injection 50 g/1000 mL (50 mg/mL) bags, Rx Only, Nephron 503B outsourcing facility, 45... Jun 30, 2022 FDA drug enforcement
Lack of Assurance of Sterility
Class II Reported terminated
Distribution: Nationwide in the USA
Official source for Atropine Sulfate Injection, USP 1.2 mg/3 mL (0.4 mg/mL) syringe, packaged in 5 x 3 mL Pre-Filled ... Jun 30, 2022 FDA drug enforcement
Lack of Assurance of Sterility
Class II Reported terminated
Distribution: Nationwide in the USA
Official source for 0.125% Bupivacaine HCl Injection, USP, 62.5 mg/50 mL (1.25 mg/mL) syringes, packaged in 5 x 50 mL... Jun 30, 2022 FDA drug enforcement
Lack of Assurance of Sterility
Class II Reported terminated
Distribution: Nationwide in the USA
Official source for 0.9% Buffered Lidocaine HCl (buffered in 8.4% Sodium Bicarbonate), 45 mg/5 mL (9 mg/mL) syringes,...
Reasons in these listed records Lack of Assurance of Sterility: There is a potential for leakage at the IV bottle port. Lack of Assurance of Sterility CGMP Deviations: Potential for cross contamination due to product carry over. CGMP Deviations: Potential for cross-contamination due to product carryover during manufacturing. These examples come from this result page and are not a ranking of every recall reason.
Checking Nephron Sterile Compounding Center LLC Is there a recall on nephron sterile compounding center llc right now? This archive contains 73 records, including 0 with agency-reported ongoing status. The status field can be incomplete or stale. Open the current official notice and match your exact product.
How do I check my package or product? Compare the product, firm and lot, date, model or serial identifiers with the notice. Use the label-check guide if you need help locating an identifier.
Does a matching name mean every item is included? A name is a search match. The agency notice sets the affected products and identifiers. Do not assume that every item with the same name or brand belongs to the recall.
What if the search finds no matching record? This search has source and keyword limits. Missing records or a missing lot code do not establish that a product is unaffected. Check source coverage and the agency's current notices.
Where can I find older records? Use monthly archives or the local search. The initial import covers records dated from October 2021 where available; each source's actual first and latest dates appear on the coverage page.